title: Idiopathic pulmonary fibrosis and cyclosporine: a lesson from single-lung transplantation.
abstract: Idiopathic pulmonary fibrosis (IPF) has a poor prognosis and therapeutic options are limited with a 5-year survival of less than 50%. This report includes a case of histologically confirmed IPF in a patient whose native lung showed objective improvement as measured by high-resolution CT while he was receiving cyclosporine-based immunosuppressive therapy after single-lung transplantation.
authors.affiliation: North West Lung Centre, Wythenshawe Hospital, Manchester, United Kingdom.
authors.forename: S S
authors.initials: SS
authors.lastname: Lok
authors.forename: E
authors.initials: E
authors.lastname: Smith
authors.forename: H M
authors.initials: HM
authors.lastname: Doran
authors.forename: R
authors.initials: R
authors.lastname: Sawyer
authors.forename: N
authors.initials: N
authors.lastname: Yonan
authors.forename: J J
authors.initials: JJ
authors.lastname: Egan
mesh_terms: D016572:Cyclosporine / Q000627:therapeutic use*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008168:Lung / Q000000981:diagnostic imaging / Q000473:pathology; D016040:Lung Transplantation; D008297:Male; D008875:Middle Aged; D011658:Pulmonary Fibrosis / Q000000981:diagnostic imaging / Q000473:pathology / Q000601:surgery* / Q000628:therapy; D011859:Radiography
chemical_list: D007166:Immunosuppressive Agents; D016572:Cyclosporine